María Gloria González-Fernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
María Gloria González-Fernández has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Agustín Mayo-Iscar
Departamento de Estadística e Investigación Operativa & IMUVA, Universidad de Valladolid, 47011 Valladolid, Spain
1 shared publication - Arroyo-Jiménez
Department of Internal Medicine, Hospital Universitario Río Hortega (HURH), Valladolid, Spain
1 shared publication - Carla Daniela Guantay
Instituto Universitario de Oftalmobiología Aplicada (IOBA Eye Institute), Universidad de Valladolid, Valladolid, Spain
1 shared publication - Cazorla-González
Department of Internal Medicine, Hospital Universitario Río Hortega (HURH), Valladolid, Spain
1 shared publication - Hernández-Gómez
Department of Internal Medicine, Hospital Universitario Río Hortega (HURH), Valladolid, Spain
1 shared publication - Jesús Fernando García-Cruces-Méndez
Department of Preventive Medicine and Hospital Epidemiology, Hospital Universitario Río Hortega, Gerencia Regional de Salud de Castilla y Leon (SACYL), Valladolid, Spain
1 shared publication
Latest Publications
- Open Access
- 4 July 2024
- Published by MDPI AG in Journal of Eye Movement Research
- Vol. 17 (2)
Accounting for visual field abnormalities when using eye-tracking to diagnose reading problems in neurological degeneration
State-of-the-art eye trackers provide valuable information for diagnosing reading problems by measuring and interpreting people’s gaze paths as they read through text. Abnormal conditions such as visual field defects, however, can seriously confound most of today’s existing methods for interpreting reading gaze patterns. Our objective was to research how visual field defects impact reading gaze path patterns, so the effects of such neurological pathologies can be explicitly incorporated into more comprehensive reading diagnosis methodologies. A cross-sectional, non-randomized, pilot clinical study including 45 patients with various neurologic disorders and 30 normal controls was designed. Participants underwent ophthalmologic/neuropsychologic and eye-tracker examinations using two reading tests of words and numbers. The results showed that the use of the eye tracker showed that patients with brain damage and an altered visual field require more time to complete a reading-text test by fixating a greater number of times (p < 0.001); with longer fixations (p = 0.03); and a greater number of saccades in these patients (p = 0.04). Our study showed objective differences in eye movement characteristics in patients with neurological diseases and an altered visual field who complained of reading difficulties. These findings should be considered as a bias factor and deserve further investigation.
- 4 July 2024
- Published by MDPI AG in Journal of Eye Movement Research
- Vol. 17 (2)
Open AccessAccounting for visual field abnormalities when using eye-tracking to diagnose reading problems in neurological degeneration
State-of-the-art eye trackers provide valuable information for diagnosing reading problems by measuring and interpreting people’s gaze paths as they read through text. Abnormal conditions such as visual field defects, however, can seriously confound most of today’s existing methods for interpreting reading gaze patterns. Our objective was to research how visual field defects impact reading gaze path patterns, so the effects of such neurological pathologies can be explicitly incorporated into more comprehensive reading diagnosis methodologies. A cross-sectional, non-randomized, pilot clinical study including 45 patients with various neurologic disorders and 30 normal controls was designed. Participants underwent ophthalmologic/neuropsychologic and eye-tracker examinations using two reading tests of words and numbers. The results showed that the use of the eye tracker showed that patients with brain damage and an altered visual field require more time to complete a reading-text test by fixating a greater number of times (p < 0.001); with longer fixations (p = 0.03); and a greater number of saccades in these patients (p = 0.04). Our study showed objective differences in eye movement characteristics in patients with neurological diseases and an altered visual field who complained of reading difficulties. These findings should be considered as a bias factor and deserve further investigation.
- Open Access
- 10 September 2020
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 15 (8) , 1533-1544
Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events
Infection with SARS-CoV-2 is becoming the leading cause of death in most countries during the 2020 pandemic. The objective of this study is to assess the association between COVID-19 and cause-specific death. The design is retrospective cohort study. We included data from inpatients diagnosed with COVID-19 between March 18 and April 21, 2020, who died during their hospital stay. Demographic, clinical and management data were collected. Causes of death were ascertained by review of medical records. The sample included 128 individuals. The median age was 84 (IQR 75–89), 57% were men. In 109 patients, the death was caused by SARS-CoV-2 infection, whereas in 19 (14.8%, 95 CI 10–22%), the infection acted only as a precipitating factor to decompensate other pathologies. This second group of patients was older (88y vs 82, p < 0.001). In age-adjusted analysis, they had a greater likelihood of heart failure (OR 3.61 95% CI 1.15–11.32), dependency in activities of daily living (OR 12.07 95% CI 1.40–103.86), frailty (OR 8.73 95% CI 1.37–55.46). The presence of X-ray infiltrates was uncommon (OR 0.07, 95% CI 0.02–0.25). A higher percentage of patient deaths from causes unrelated to COVID-19 complications occurred during the two first weeks of the pandemic. Fifteen percent of patients with COVID-19 infection died from decompensation of other pathologies and the cause of death was unrelated to COVID-19 severe complications. Most of these patients had more comorbidities and were frail and elderly. These findings can partially explain the excess mortality in older people. Graphic abstract
- 10 September 2020
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 15 (8) , 1533-1544
Open AccessCause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events
Infection with SARS-CoV-2 is becoming the leading cause of death in most countries during the 2020 pandemic. The objective of this study is to assess the association between COVID-19 and cause-specific death. The design is retrospective cohort study. We included data from inpatients diagnosed with COVID-19 between March 18 and April 21, 2020, who died during their hospital stay. Demographic, clinical and management data were collected. Causes of death were ascertained by review of medical records. The sample included 128 individuals. The median age was 84 (IQR 75–89), 57% were men. In 109 patients, the death was caused by SARS-CoV-2 infection, whereas in 19 (14.8%, 95 CI 10–22%), the infection acted only as a precipitating factor to decompensate other pathologies. This second group of patients was older (88y vs 82, p < 0.001). In age-adjusted analysis, they had a greater likelihood of heart failure (OR 3.61 95% CI 1.15–11.32), dependency in activities of daily living (OR 12.07 95% CI 1.40–103.86), frailty (OR 8.73 95% CI 1.37–55.46). The presence of X-ray infiltrates was uncommon (OR 0.07, 95% CI 0.02–0.25). A higher percentage of patient deaths from causes unrelated to COVID-19 complications occurred during the two first weeks of the pandemic. Fifteen percent of patients with COVID-19 infection died from decompensation of other pathologies and the cause of death was unrelated to COVID-19 severe complications. Most of these patients had more comorbidities and were frail and elderly. These findings can partially explain the excess mortality in older people. Graphic abstract